glp 1 clinical trials The GLP-1 Trial Landscape in 2024 Clinical trials suggest GLP-1s may
Description
While GLP-1 agonists produce dramatic results for many patients, a meaningful subset achieves suboptimal weight loss or experiences diminishing efficacy over time
Therefore, choosing nutrient-rich foods is key to preventing side effects of Compounded GLP-1s
When it came to weight loss, the high-dose group lost an average of 7.9% of body weight , equivalent to about 16 pounds (7.3 kg) , compared to just 2.9 pounds (1.3 kg) in the placebo group
In contrast, lean individuals with stable glucose patterns may see limited value
Methods This systematic review was conducted across PubMed/MEDLINE and Web of Science
